Prophylaxis and therapy for rhinitis and sinusitis
CA2649597A1
Mono and combination therapy of m1/m4 agonist (sabcomeline) for treatment of negative symptoms of schizophrenia
CA2649601A1
Mono and combination therapy with a m1/m4 muscarinic agonist (sabcomeline) for treatment of cognitive disorders in schizophrenia
GB0607952D0
Novel treatment
BRPI0518567A2
pharmaceutical composition, uses of a pharmaceutical composition, sabcomelin or a pharmaceutically acceptable salt thereof, at least one neuroleptic agent and a combination of sabcomelin or a pharmaceutically acceptable salt thereof and at least one neuroleptic agent, parts kit for use in the treatment of a psychotic duster, method of treating a psychotic disorder, and sabcomelin or a pharmaceutically acceptable salt thereof
EP1835914A1
Sabcomeline alone or combined with a mood stabilising or antimanic agent to treat bipolar disorders
